Toggle navigation
Home
Search
Services
Blog
Contact
About
A Phase Iib Cancer Prevention Trial of Nsaids in Oral Leukoplakia - Ws -261025011
Fox Chase Cancer Center (INC)
Search grants from Fox Chase Cancer Center (INC)
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Synovial Cadherin in Rheumatoid Arthritis
Minority Predoctoral Fellowship Program
Logistical Support for Workgroups on Alzheimers Disease
Determinants of Contraceptive Use in Adolescent Males
Studies with Growth Hormone Releasing Factor
Recently added grants:
Structure and Dynamics of the Telomerase Ribonucleoprotein
An Interbacterial Adaptive Immune System Encoded by Bacteroidales
Investigations of Pathologic Remodeling Using Pediatric Heart Failure Serum
Exploiting Ecology and Evolution to Prevent Therapy Resistance in EGFR-Driven Lung Cancer
Preclinical Time domain Fluorescence Tomography Platform
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA025011-000
Application #
6688657
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2002
Total Cost
Indirect Cost
Institution
Name
Fox Chase Cancer Center (INC)
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2003
N01 CA
A Phase Iib Cancer Prevention Trial of Nsaids in Oral Leukoplakia - Ws -261025011
/ Fox Chase Cancer Center (INC)
NIH 2002
N01 CA
A Phase Iib Cancer Prevention Trial of Nsaids in Oral Leukoplakia - Ws -261025011
/ Fox Chase Cancer Center (INC)
Comments
Be the first to comment on this grant